Molina Healthcare, Inc
MOH Healthcare Healthcare Plans
Molina Healthcare, Inc’s revenue for fiscal 2025 (year ended December 2025) was $45.4 billion, up 11.7% from fiscal 2024.
- Revenue
- −3.44%
- EPS
- −51.7%
- Free cash flow
- −20.3%
- Total debt
- +2.54%
Quarter to September 2026, against a year earlier
Follow MOH
Alert me
Molina Healthcare, Inc (MOH) EPS (diluted)
Molina Healthcare, Inc's EPS (diluted) for fiscal 2025 was $8.92, down 56.3% from $20.42 in fiscal 2024. Over the twelve months to 30 September 2026 it was −$0.96. Over the past ten years it has ranged from −$9.07 (fiscal 2017) to $20.42 (fiscal 2024); the current reading is higher than 36% of that period. Molina Healthcare, Inc ranks 12th of 12 Healthcare Plans companies by EPS (diluted).
EPS (diluted), annual
Embed this chart
Annual newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| FY2025 | $8.92 | (56.32%) |
| FY2024 | $20.42 | 8.79% |
| FY2023 | $18.77 | 38.52% |
| FY2022 | $13.55 | 20.44% |
| FY2021 | $11.25 | 0.18% |
| FY2020 | $11.23 | (2.09%) |
| FY2019 | $11.47 | 8.11% |
| FY2018 | $10.61 | — |
| FY2017 | −$9.07 | — |
| FY2016 | $0.93 | (64.00%) |
Quarterly newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| Sep 2026 | $0.73 | (38.66%) |
| Jun 2026 | $1.19 | 340.74% |
| Mar 2026 | $0.27 | — |
| Dec 2025 | −$3.15 | — |
| 43 more quarters | Free account |
Against its own ten years
EPS (diluted) against peers
| Company | EPS (diluted) |
|---|---|
| CI Cigna Group compare | $23.63 |
| ELV Elevance Health, Inc. compare | $23.45 |
| HUM Humana Inc. compare | $10.28 |
| CNC Centene Corporation compare | $2.93 |
| OSCR Oscar Health, Inc. compare | $2.42 |
| PGNY Progyny, Inc. compare | $1.09 |
| ALHC Alignment Healthcare, Inc. compare | $0.13 |
| CLOV Clover Health Investments, Corp. compare | −$0.05 |
| MOH Molina Healthcare, Inc | −$0.96 |
What EPS (diluted) is
Diluted EPS tells an investor how much profit a company earned for each share, counting the extra shares that options and convertible securities could create.
Reported line item
More on MOH
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement